Phase II Study to Evaluate the Efficacy of Recombinant Interferon-Alpha in the Treatment of Recurrent Unresectable Meningiomas and Malignant Meningiomas
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- 30 Jul 2012 Biomarkers information updated
- 24 Sep 2005 New trial record.